Global Sleep Apnea Devices Market Overview
Sleep Apnea Devices Market was valued at US$ 6.2 Billion in 2024 and is projected to grow at a CAGR of 6.70% to reach US$ 11.8 Billion by 2034.
Apnea occurs when the body and brain receive insufficient oxygen and breathing process is interrupted during sleep. OSA is the most common form of apnea caused by airway blockage. In order to avoid this, it is necessary for patients to undergo diagnostic tests and use therapeutic treatment devices. OSA is widely prevalent in the elderly population, patients suffering from cardiovascular diseases, and other non-communicable diseases such as diabetes, hypertension, and remains underdiagnosed owing to lack of awareness, poor healthcare infrastructure in developing countries, and non-specific presentation of the disease. There are different types of treatment options are available to recover sleep apnea. For example, wear an oral device, surgery for sleep apnea, undergoing a weight management, positional therapy and behaviors therapy. Additionally, Hypoglossal Nerve Stimulation, Expiratory Positive Airway Pressure, Positive Airway Pressure Therapy, Oral Pressure Therapy these are some latest therapy which is used in sleep apnea.
Global Sleep Apnea Devices Market Segmentation
Sleep apnea devices market is segmented based on diagnostic devices, therapeutic devices, end user and region.
On the basis of diagnostic devices, the sleep apnea devices market is segmented into polysomnography devices, pulse oximeters, and actigraphy devices. Based on therapeutic devices, the target market is classified into positive airway pressure (pap) devices, (continuous positive airway pressure (cPAP) devices, and bi-level positive airway pressure (biPAP) devices), oxygen devices (oxygen concentrators, portable oxygen concentrators, and liquid portable oxygen), oral appliances, adaptive servo ventilation (asv) devices, and masks and accessories. Based on end user, the global market is characterized into sleep laboratories and hospitals, and home care settings/individuals.
Regional Insights:
On region the sleep apnea devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America dominates the global market in terms of revenue and is projected to continue its dominance in the coming years. This region is expected to increase its market share in the future, owing to the high incidence of sleep-disordered breathing (SDB) and rising aging population in the region. Asia Pacific is projected to be the fastest growing market over the forecast period with a CAGR of 15.2% over the forecast period. Asia Pacific has the largest number of undiagnosed sleep apnea patients in the world. This presents a lucrative opportunity for the manufacturers.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Diagnostic Devices - Polysomnography Devices, Pulse Oximeters, and Actigraphy Devices By Therapeutic Devices – Positive Airway Pressure (PAP) Devices, (Continuous Positive Airway Pressure (CPAP) Devices, and Bi-Level Positive Airway Pressure (BiPAP) Devices), Oxygen Devices (Oxygen Concentrators, Portable Oxygen Concentrators, and Liquid Portable Oxygen), Oral Appliances, Adaptive Servo Ventilation (ASV) Devices, and Masks and Accessories By End User - Sleep Laboratories and Hospitals, and Home Care Settings/Individuals |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the sleep apnea devices market report based on diagnostic devices, therapeutic devices, end user and region:
Sleep Apnea Devices Market, By Diagnostic Devices:
- Polysomnography Devices
- Pulse Oximeters
- Actigraphy Devices
Sleep Apnea Devices Market, By Therapeutic Devices:
- Positive Airway Pressure (PAP) Devices
- Continuous Positive Airway Pressure (CPAP) Devices
- Bi-Level Positive Airway Pressure (BiPAP) Devices
- Oxygen Devices
- Oxygen Concentrators
- Portable Oxygen Concentrators
- Liquid Portable Oxygen
- Oral Appliances
- Adaptive Servo Ventilation (ASV) Devices
- Masks and Accessories
Sleep Apnea Devices Market, By End User:
- Sleep Laboratories and Hospitals
- Home Care Settings/Individuals
Sleep Apnea Devices Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Global Sleep Apnea Devices Market Key Players
The key players operating the Sleep Apnea Devices market includes GE Healthcare, Fisher & Paykel Healthcare Limited, BMC Medical Co. Ltd, Cadwell Laboratories ResMed, Invacare Corporation, Braebon Medical Corporation, ImThera Medical Inc., Phillips Respironics, Curative Medical Inc., and Nihon Kohden. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.
For instance, in August 2019, American Thoracic Society announced that Oral appliances may be highly effective in treating a type of sleep apnea. In April 2019, Hiroshima University Researchers measured a novel treatment for sleep apnea and found positive results. By measuring patients lying down flat, the researchers stimulated sleep conditions and measured the patient's airways using 3D imaging. The study confirmed that the treatment is effective at opening the airways and warrants further collaboration between dentists and doctors in treatment of sleep apnea.
Global Sleep Apnea Devices Market Company Profile
- GE Healthcare
-
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
-
- Fisher & Paykel Healthcare Limited
- BMC Medical Co. Ltd
- Cadwell Laboratories ResMed
- Invacare Corporation
- Braebon Medical Corporation
- ImThera Medical Inc.
- Phillips Respironics
- Curative Medical Inc.
- Nihon Kohden
“*” marked represents similar segmentation in other categories in the respective section
Global Sleep Apnea Devices Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for Sleep Apnea Devices Strategies
- Key Questions this Study will Answer
- Market Snippet, By Diagnostic Devices
- Market Snippet, By Therapeutic Devices
- Market Snippet, By End User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Diagnostic Devices, 2024 – 2034, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Segment Trends
- PolysoBnography Devices
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Pulse Oximeters
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Actigraphy Devices
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Overview
- Market Segmentation, By Therapeutic Devices, 2024 – 2034, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Segment Trends
- Positive Airway Pressure (PAP) Devices
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Continuous Positive Airway Pressure (CPAP) Devices
- Bi-Level Positive Airway Pressure (BiPAP) Devices
- Oxygen Devices
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Oxygen Concentrators
- Portable Oxygen Concentrators
- Liquid Portable Oxygen
- Oral Appliances
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Adaptive Servo Ventilation (ASV) Devices
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Masks and Accessories
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Overview
- Market Segmentation, By End User, 2024 – 2034, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Segment Trends
- Sleep Laboratories and Hospitals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Home Care Settings/Individuals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2024 – 2034
- Overview
- Global Market, By Region, 2024 – 2034, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2024 – 2034
- Y-o-Y Growth Analysis (%), 2024 – 2034
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Diagnostic Devices, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Therapeutic Devices, 2024 – 2034
- Market Size and Forecast (US$ Bn), By End User, 2024 – 2034
- Market Sleep Apnea Devices and Forecast (US$ Bn), By Country, 2024 – 2034
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Diagnostic Devices, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Therapeutic Devices, 2024 – 2034
- Market Size and Forecast (US$ Bn), By End User, 2024 – 2034
- Market Sleep Apnea Devices and Forecast (US$ Bn), By Country, 2024 – 2034
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Diagnostic Devices, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Therapeutic Devices, 2024 – 2034
- Market Size and Forecast (US$ Bn), By End User, 2024 – 2034
- Market Sleep Apnea Devices and Forecast (US$ Bn), By Country, 2024 – 2034
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Diagnostic Devices, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Therapeutic Devices, 2024 – 2034
- Market Size and Forecast (US$ Bn), By End User, 2024 – 2034
- Market Sleep Apnea Devices and Forecast (US$ Bn), By Country, 2024 – 2034
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Diagnostic Devices, 2024 – 2034
- Market Size and Forecast (US$ Bn), By Therapeutic Devices, 2024 – 2034
- Market Size and Forecast (US$ Bn), By End User, 2024 – 2034
- Market Sleep Apnea Devices and Forecast (US$ Bn), By Country, 2024 – 2034
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- GE Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Fisher & Paykel Healthcare Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- BMC Medical Co. Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Cadwell Laboratories ResMed
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Invacare Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Braebon Medical Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- ImThera Medical Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Phillips Respironics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Curative Medical Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Nihon Kohden
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- GE Healthcare
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The market report has been segmented on the basis of diagnostic devices, therapeutic devices, end user, and region
The growing incidence rate of chronic conditions is expected to increase the burden of OSA
North America accounted for the largest revenue share
GE Healthcare, Fisher & Paykel Healthcare Limited, BMC Medical Co. Ltd, Cadwell Laboratories ResMed, Invacare Corporation, Braebon Medical Corporation, ImThera Medical Inc., Phillips Respironics, Curative Medical Inc., and Nihon Kohden